improve human health News
-
New Biocides Regulation improves human health and environmental protection
A new Regulation on biocidal products applying from 1st September will significantly increase the safety and simplify the authorisation procedure of biocides used and placed on the market in the EU. Biocides are chemicals used to suppress harmful organisms such as pests and germs (i.e. moulds and bacteria), including insect repellents, disinfectants and industrial chemicals like anti-fouling ...
-
Portland receives $100K EPA grant to improve environmental health for Citizens (ME)
With the help of a $100,000 grant from EPA, the City of Portland will address local environmental issues, including to implement EPA strategies for reducing exposures to local toxic pollutants. The grant is part of EPA’s Community Action for a Renewed Environment (CARE) program. CARE is an initiative to help community groups identify and address the critical environmental health issues in ...
-
New Research Collaboration with Janssen Biotech
Immune Biosolutions Inc. (IBio), a JLABS @ Toronto resident company, today announced a research collaboration and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement, facilitated by Johnson & Johnson Innovation LLC, will focus initially on the discovery and development of therapeutic antibodies in oncology. The ...
-
Radiopharm Theranostics signs agreement with ANSTO for the supply of key isotope lutetium-177
bydney, Australia - November n, lull — Kaaiopnarm I neranostics (A:>a:kauj, a aeveioper or a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce agreement with Australia's Nuclear Science and Technology Organisation (ANSTO) to supply the Company with isotope non-carrier-added lutetium-177 (Lu-177) for its trials in ...
-
Celdara Medical Announces Funding for Alzheimer’s-Focused Fellowship Opportunities
Celdara Medical, LLC today announced that the National Institute of Aging’s Research and Entrepreneurial Development Immersion (REDI) initiative has awarded an R25 Entrepreneurship Enhancement Award to fund the company’s comprehensive training program focused on Alzheimer’s Disease: the Alzheimer’s-focused Celdara Medical High-Potential Entrepreneurs’ Fellowship ...
-
Collaboration demonstrated in established top-notch degree program
San Antonio is known for collaboration and mutual support in the life science sector. The Translational Science (TS) PhD degree program is one such example. A joint degree program between the UT Health San Antonio, UTSA, and UT Austin (the degree-granting institutions) and the UT School of Public Health (as a collaborating institution), the TS PhD degree program was established and approved by ...
By BioMedSA
-
Synbiotic Health Appoints Erin Vyhlidal as VP Corporate Finance
Microbiome-based ingredient company Synbiotic Health is pleased to announce the appointment of Erin Vyhlidal as Controller and Vice President, Corporate Finance. Vyhlidal is a CPA (inactive registrant) with twenty years’ experience in accounting. She previously oversaw a team of nine as VP Corporate Finance at Farmers National Company in Omaha, NE, after working at PricewaterhouseCoopers as ...
-
Creative Enzymes Offers Personalized and Customized Probiotic Blends
Creative Enzymes, a professional enzyme provider located in New York, USA, is always hammering away at research and trials in order to provide customers with enzyme services and products with its greatest effort. The company provides high-quality and pure multi-strain probiotic custom blends to meet clients’ unique application goals and health demands. In addition, the introduction of ...
-
Kallyope Announces CEO Transition as Company Advances to its Next Stage of Growth
Kallyope Inc., a leading biotechnology company focused on identifying and pursuing novel therapeutics involving the gut-brain axis, today announced that the Board of Directors has appointed Jay Galeota as President and he will succeed Nancy Thornberry as Chief Executive Officer by October 1, 2021. Mr. Galeota also joins the Kallyope Board of Directors. Ms. Thornberry will remain actively involved ...
-
Synbiotic Health Welcomes Kevin Hooper as Director of Business Development
Microbiome-based ingredient company Synbiotic Health announces that Kevin Hooper has joined the company as Director of Business Development. Hooper has more than 14 years’ experience in sales and business development, most recently at the global ingredient supplier IFF Health. At Synbiotic Health he will work with Steve Prescott, Senior Vice President of Business Development, to implement ...
-
DRIVEN Alumni Surpass $50M in Follow-on Funding
February 22, 2022 – Celdara Medical, LLC today announced that alumni of their DRIVEN Partnership Program have collectively surpassed $50M in follow-on funding. DRIVEN was established in 2018 as the Northeast’s NIH-funded Accelerator Hub. Led by Celdara Medical and Simbex, it has always had a singular goal: improve human health by increasing the number, quality, and success rate of ...
-
Celdara Medical Names Entrepreneur Fellows
Celdara Medical, LLC today announced the selection of five outstanding researchers as the recipients of the 2021 Celdara Medical High-Potential Entrepreneurs’ Fellowships (CHEF). The program provides a part-time, year-long experiential learning opportunity at Celdara to senior graduate students and post-doctoral researchers. Fellows receive an opportunity to hone their executive skills ...
-
Nature in urban environments reduces stress
Contact with nature in urban areas can have numerous health benefits, a new study finds. The researchers found people whose homes had views of different kinds of vegetation had significantly lower levels of stress hormones, indicating that green spaces play an important role in healthy cities. Urban nature — such as trees and public parks — is beneficial to human health. A number of ...
-
Healthcare Industry Leader Scott Serota Joins Theranica Board of Directors
Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced the appointment of Scott Serota to its Board of Directors. "Over the course of the past few decades, which I have dedicated to enabling patients of various medical conditions access to new treatments, I developed passion for supporting the advancement ...
-
CD Genomics MicrobioSeq Releases Microbial Transcriptomics for Disease Research and Drug Development
MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable de novo sequencing, genotyping, microarray, and bioinformatics services. With years of experience in the pharmaceutical and life science sectors, CD Genomics has announced Microbial Transcriptomics ...
By CD Genomics
-
Virginia Catalyst Awards Contraline S600,000 for Clinical Translation
RICHMOND, VA – October 26, 2020 – The Virginia Catalyst, formerly known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2.1 million in grants to three life and bioscience projects in the Commonwealth of Virginia. These grants, which will be met with significant matching funds from partner companies, were awarded as Round 11 of ...
-
Sage Therapeutics and Biogen to Host Investor Webcast on December 6, 2022 to Discuss Potential Commercialization Plans for Zuranolone
Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) today announced that the companies will host a joint investor webcast to discuss the planned commercialization approach and opportunity for their investigational product, zuranolone, on Tuesday, December 6 at 8:00 a.m. ET. Zuranolone is being evaluated as a potential rapid-acting, once-daily, oral two-week treatment for major ...
-
Agilent Technologies Presents Thought Leader Award to Human Microbiome Expert Jeffrey Gordon
Agilent Technologies Inc. (NYSE: A) today announced that Dr. Jeffrey Gordon has received an Agilent Thought Leader Award in support of his pioneering research into the mutually beneficial relationship between the human body and the tens of trillions of microbes that inhabit the gastrointestinal tract. Dr. Gordon directs the Center for Genome Sciences and Systems Biology at Washington University ...
-
EMOTIV Enlists Two Machine Learning Heavyweights as AI Takes Aim at the Human Brain
EMOTIV, the bioinformatics pioneer advancing understanding of the human brain using electroencephalography (EEG), today added two renowned scientists to its executive leadership team, naming Dr. Gary William Flake as Chief Technology Officer (CTO) and Dr. Scott Rickard as Chief AI Scientist. The new hires underscore EMOTIV’s strategic objectives to meet the quickening pace of advancements ...
By Emotiv Inc.
-
Male Contraceptive Initiative Invests SI Million in Contraline
RICHMOND, VA – October 26, 2020 – The Virginia Catalyst, formerly known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2.1 million in grants to three life and bioscience projects in the Commonwealth of Virginia. These grants, which will be met with significant matching funds from partner companies, were awarded as Round 11 of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you